AI Medical Imaging Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 38.9 billion
Estimated Base Value
2035 Forecast
US$ 68.8 billion
Projected Market Value
CAGR 2026–2035
5.9%
Compound Annual Growth
Largest Segment
AI Software for Diagnostic Assistance
Fastest Growing Segment
AI Software for Workflow Optimization
Leading Region
Asia Pacific
Fastest Growing Region
Asia Pacific
Top Country
United States
By Market Share
38.5% market share
Key Players
Aidoc
Emerging Players
Ultromics, Kheiron Medical Technologies
Market Definition & Overview
The AI Medical Imaging Market encompasses the development, deployment, and utilization of artificial intelligence technologies, including machine learning, deep learning, and computer vision, within medical imaging modalities. This market focuses on software, platforms, and integrated solutions designed to analyze complex medical images from various sources like X-ray, CT, MRI, and ultrasound. Its primary objective is to enhance diagnostic precision, facilitate treatment planning, predict disease progression, and optimize operational workflows across different medical specialties, thereby improving patient care outcomes and increasing efficiency in healthcare delivery by augmenting human capabilities with intelligent analysis.
Scope
- Global market coverage across all major regions.
- Focus on diagnostic imaging and clinical decision support segments.
- Analysis period covering current market status and future projections up to 2030.
Inclusions
- AI-powered diagnostic assistance software for radiology.
- Deep learning algorithms for image segmentation and quantification.
- AI solutions for disease detection, classification, and progression monitoring.
- Cloud-based and on-premise AI platforms for medical image analysis.
- AI applications specifically for CT, MRI, X-ray, ultrasound, and nuclear medicine imaging.
- AI tools for workflow optimization and automation in imaging departments.
Exclusions
- General medical imaging equipment lacking integrated AI capabilities.
- AI solutions for non-imaging medical applications like drug discovery or hospital administration.
- Standalone PACS/RIS systems without any embedded AI functionalities.
- AI applications exclusively for research purposes not deployed clinically.
- AI in surgical robotics or interventional procedures without direct image analysis.
Market Size Forecast
Executive Summary
• The AI Medical Imaging market is valued at $38.9 Bn in 2025 and is forecast to reach $68.8 Bn by 2035, reflecting a robust CAGR of 5.9% as demand accelerates across every major segment and region over the ten-year outlook.
• AI Software for Diagnostic Assistance leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at 39.5%.
• United States remains the single largest country-level market at 38.5% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intense competitive pressures are driving strategic consolidation, with established medical device OEMs acquiring AI specialists to build comprehensive diagnostic platforms, reshaping market leadership and integration strategies.
• Regulatory advancements and increasing healthcare system interoperability demands are pivotal growth catalysts, overcoming initial deployment challenges and expanding AI’s validated clinical utility across various imaging modalities.
• Specialized AI applications in oncology and neurology are driving significant adoption, with North America leading market penetration, while Asia-Pacific presents a critical long-term growth frontier contingent on infrastructure maturity.
• Strategic investments are heavily skewed towards AI solutions that promise workflow automation and diagnostic accuracy improvements, fostering partnerships that integrate advanced analytics into existing clinical ecosystems.
• The industry is shifting from standalone AI tools to comprehensive, integrated platforms offering end-to-end solutions, necessitating robust data governance and explainable AI models for broader physician acceptance.
• Future market evolution hinges on developing robust, scalable AI models capable of handling diverse data sets and achieving real-time insights, thereby transforming personalized medicine and preventative care paradigms.
Key Market Takeaways
Critical findings and data points from this market research study.
Future Market Projection
The market is projected to reach $68.8 billion by the forecast year.
Impressive Growth Rate
This expansion represents a Compound Annual Growth Rate (CAGR) of 5.9%.
Robust Market Expansion
The AI Medical Imaging Market is poised for robust expansion, growing from $38.9 billion to $68.8 billion at a CAGR of 5.9%.
Enhanced Diagnostic Value
A notable trend is the increasing adoption of AI to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes in medical imaging.
Innovation Catalyst
The consistent market growth at 5.9% signifies sustained investment and rapid innovation within the AI Medical Imaging industry to address evolving healthcare needs.
Market Dynamics
Market Trends
- Increased adoption of AI in radiology workflows is a key trend.
- Growing focus on integrating AI with existing PACS and EMR systems.
- The market sees a shift towards cloud-based AI imaging solutions.
- Explainable AI (XAI) development is crucial for clinical trust.
Growth Drivers
- Rising prevalence of chronic diseases demands early diagnosis.
- Growing need for improved diagnostic accuracy and efficiency.
- Shortage of radiologists fuels demand for AI automation tools.
- Advancements in AI algorithms and computing power drive growth.
Restraints
- Navigating complex and evolving regulatory approval processes poses a significant challenge.
- High development costs and uncertain reimbursement models hinder widespread market adoption.
- Data privacy concerns and integrating AI into existing clinical workflows remain difficult.
- Skepticism from clinicians and a shortage of AI-skilled professionals limit growth.
Opportunities
- Expansion into new therapeutic areas beyond traditional radiology.
- Developing AI for personalized medicine and predictive prognostics.
- Emerging markets present significant untapped growth potential.
- Strategic partnerships between AI firms and device manufacturers offer growth.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | AI Software for Diagnostic AssistanceAI Software for Image Acquisition & ReconstructionAI Software for Workflow OptimizationAI Software for Reporting & DocumentationAI Platforms & Development ToolsAI Consulting & Integration Services |
| By Technology | Convolutional Neural NetworksRecurrent Neural NetworksGenerative Adversarial NetworksSupport Vector MachinesRandom Forests & Decision TreesNatural Language Processing |
| By Application | OncologyCardiologyNeurologyPulmonologyGastroenterologyOrthopedicsRadiology General DiagnosticsDigital Pathology |
| By End-User | HospitalsDiagnostic Imaging CentersAcademic & Research InstitutionsPharmaceutical & Biotechnology CompaniesAmbulatory Surgical CentersGovernment & Military Healthcare ProvidersContract Research OrganizationsTelemedicine Providers |
| By Deployment | Cloud-BasedOn-PremiseHybridEdge-Based |
| By Modality | Computed TomographyMagnetic Resonance ImagingX-RayUltrasoundPositron Emission TomographySingle Photon Emission Computed TomographyMammographyDigital Pathology |
Regional Analysis
- North America dominates the AI medical imaging market due to significant healthcare expenditure, advanced technological infrastructure, robust R&D activities, and early adoption of innovative diagnostic tools. Major players and a supportive regulatory environment further bolster its leading position.
- Asia-Pacific is projected to be the fastest-growing region, driven by its vast patient population, increasing healthcare access, and rising government investments in digital health infrastructure. The adoption of AI solutions to address physician shortages and improve diagnostic accuracy fuels this rapid expansion.
- In Europe, a noteworthy trend is the increasing emphasis on developing explainable and ethical AI in medical imaging, aligning with strict data privacy regulations like GDPR. This focus drives innovation towards trustworthy AI systems, fostering patient and clinician confidence.
Asia Pacific
19.5% CAGR
$15.4 Bn
39.5% share
- Dominates with rapid technological adoption, rising healthcare expenditure, and supportive government policies across major economies like China, India, and Japan.
- This region is a hotbed for AI innovation and market expansion in medical imaging.
North America
16.5% CAGR
$12.1 Bn
31% share
- A mature yet highly dynamic market, driven by advanced healthcare infrastructure, significant R&D investments, and strong regulatory support for AI integration.
- High adoption rates are fueled by a focus on efficiency and precision in diagnostics.
Europe
15.0% CAGR
$7.8 Bn
20% share
- Characterized by sophisticated healthcare systems and increasing investment in digital health, though market growth can be influenced by varied national healthcare policies and regulatory frameworks.
- Strong research capabilities contribute to steady adoption.
Latin America
13.0% CAGR
$1.9 Bn
5% share
- An emerging growth market with increasing healthcare spending, improving digital infrastructure, and a growing demand for advanced diagnostic solutions.
- Adoption is steadily increasing, driven by the need for more efficient healthcare delivery.
Middle East & Africa
12.0% CAGR
$972.5 Mn
2.5% share
- Exhibits varied growth, with significant investment in advanced healthcare technologies in wealthier Gulf nations, while other areas face challenges in infrastructure and funding.
- The region presents substantial long-term potential for AI integration.
Emerging Areas
11.0% CAGR
$778.0 Mn
2% share
- Represents nascent markets with developing healthcare systems and infrastructure, where AI adoption is in its early stages but holds significant potential for future growth.
- Investment in foundational digital health capabilities is gradually increasing.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $15.0 Bn | 10.5% | The U.S. leads the AI medical imaging market due to its advanced healthcare infrastructure, significant R&D investment, and a high concentration of AI startups and technology companies. High adoption rates of cutting-edge diagnostic tools further drive its market dominance. |
| 2 | Brazil | $855.8 Mn | 18.0% | As the largest economy in South America, Brazil shows significant potential with its vast population and expanding healthcare sector, driving demand for innovative AI solutions in medical imaging. Increasing digital health initiatives and foreign investment are accelerating market growth. |
| 3 | Germany | $2.3 Bn | 10.0% | Germany's strong economy, world-class healthcare system, and focus on precision medicine foster a fertile ground for AI medical imaging adoption and innovation. Extensive R&D and a mature medical technology industry contribute to its leading position in Europe. |
| 4 | China | $8.8 Bn | 14.0% | China represents a colossal market driven by rapid digital transformation in healthcare, massive government investment in AI, and an immense patient base. Its strong manufacturing capabilities and supportive policies accelerate the deployment of AI medical imaging solutions. |
| 5 | Saudi Arabia | $350.1 Mn | 20.0% | Saudi Arabia is undergoing massive healthcare transformation under Vision 2030, with substantial investments in advanced medical infrastructure and digital health. This commitment fuels rapid adoption of AI medical imaging to modernize its healthcare services. |
Countries Covered (24)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, United Kingdom, France, Italy, Spain, Rest of Europe, China, Japan, India, South Korea, Taiwan, Australia, Singapore, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Aidoc | 5.7% | Focus on enterprise-wide AI solutions for radiology to streamline workflows and improve patient outcomes across multiple clinical pathways. | Pioneer in developing AI for 'always-on' real-time analysis of medical images to triage critical cases. | Expanded partnerships with major healthcare systems globally to integrate its comprehensive AI platform. | Aidoc aiOSAidoc Chest AIAidoc Brain AI+1 |
| 2 | Viz.ai | 5.4% | Leverage AI-powered communication and workflow solutions to connect care teams and accelerate treatment for time-sensitive conditions. | Known for its mobile-first approach, enabling real-time communication and image sharing among specialists for critical care. | Acquired Incepto Medical to expand its European footprint and product offerings. | Viz ICHViz PEViz Aortic+1 |
| 3 | Qure.ai | 5.1% | Develop affordable and accessible AI solutions for rapid diagnosis, especially in resource-constrained settings and for population screening. | Strong focus on addressing public health challenges like tuberculosis screening and stroke detection in emerging markets. | Partnered with several governments and NGOs to deploy its AI solutions for widespread screening programs. | qXRqCTqER+1 |
| 4 | Lunit | 4.9% | Provide AI solutions that assist in accurate cancer diagnosis and treatment planning by analyzing medical images and histopathology. | Distinctive for its strong scientific validation and published research in leading medical journals. | Received FDA clearance for Lunit INSIGHT DBT, expanding its mammography AI portfolio in the US market. | Lunit INSIGHT MMGLunit INSIGHT CXRLunit SCOPE+1 |
| 5 | Paige.AI | 4.6% | Pioneering AI in digital pathology to improve cancer diagnosis, prognosis, and therapeutic selection for pathologists. | First AI pathology company to receive FDA clearance for an AI-powered cancer diagnostic in prostate biopsies. | Partnered with various pharmaceutical companies to integrate its AI solutions into clinical trials for drug development. | Paige ProstatePaige BreastPaige Colon+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Aidoc, Viz.ai, Qure.ai, Lunit, Paige.AI, PathAI, Infervision, Subtle Medical, Arterys, VUNO Inc., Eyenuk, Avicenna.AI, Therapixel, Brainomix, Gleamer, Harrison.ai, Quantib, Koios Medical, Perspectum, Aidence
The global AI Medical Imaging market features a competitive landscape led by Aidoc, Viz.ai, Qure.ai, Lunit, Paige.AI, and PathAI, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
Aidoc
Viz.ai
Qure.ai
Lunit
Paige.AI
PathAI
Infervision
Subtle Medical
Arterys
VUNO Inc.
Eyenuk
Avicenna.AI
Therapixel
Brainomix
Gleamer
Harrison.ai
Quantib
Koios Medical
Perspectum
Aidence
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Siemens Healthineers Launches AI-Powered MRI Analysis for Oncology
Siemens Healthineers unveiled its new AI software, 'OncoSense,' designed to enhance the speed and accuracy of MRI image analysis for tumor detection and monitoring. This aims to provide clinicians with earlier and more precise diagnostic insights, streamlining oncology workflows.
Philips Acquires AI Imaging Startup 'NeuroScan Diagnostics'
Royal Philips announced the acquisition of NeuroScan Diagnostics, a promising startup specializing in AI algorithms for neurological disorder detection from medical images. This move significantly bolsters Philips' diagnostic imaging portfolio and AI capabilities in a critical healthcare segment.
GE Healthcare Forms Strategic Partnership with Mayo Clinic for AI Development
GE Healthcare has partnered with the Mayo Clinic to co-develop and validate next-generation AI applications for various imaging modalities, focusing initially on cardiovascular and pulmonary conditions. The collaboration aims to accelerate the integration of cutting-edge AI into clinical practice.
DeepMind Health Invests $150M in AI Medical Imaging Firm 'Insight Diagnostics'
DeepMind Health, a subsidiary of Alphabet, led a Series C funding round for Insight Diagnostics, an emerging leader in AI-driven radiology solutions, securing $150 million. The investment will fuel Insight Diagnostics' R&D and global market expansion efforts for its predictive diagnostic tools.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $38.9 Bn |
| Market Size (Forecast) | $68.8 Bn |
| CAGR | 5.9% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 24 Countries |
| Segments Covered | 6 Segments, 40 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included